The results showed that treatment with BML-111 significantly reduces the size of stroke and protects the cerebral cortex, possibly by reducing BBB permeability, reducing MMP-9 and MMP-3, reducing microglia activation, and protecting tight junctions [76]. Here, MMP9 is linked to stroke disorder.